More Data Needed for Decision on Booster Shots, U.S. Officials Tell Pfizer
After meeting with company representatives, officials said the decision would depend partly on data on infections in vaccinated people that cause serious disease or hospitalization.
View original article
Contributor: Sheryl Gay Stolberg and Sharon LaFraniere
